cyclic cmp has been researched along with betadex in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gupte, SA; Masumiya, H; Ochi, R; Okada, T; Song, Y; Tsujikawa, H; Watanabe, M | 1 |
1 other study(ies) available for cyclic cmp and betadex
Article | Year |
---|---|
Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; beta-Cyclodextrins; Calcium Channel Agonists; Calcium Channels, L-Type; Calcium Signaling; Cholesterol; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic CMP; Dose-Response Relationship, Drug; Enzyme Activators; Heart Ventricles; In Vitro Techniques; Isoproterenol; Membrane Microdomains; Membrane Potentials; Myocytes, Cardiac; Rabbits; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Time Factors | 2008 |